CME Supplements

Counseling Your Patients About Hypoactive Sexual Desire Disorder and Advances in its Diagnosis and Treatment

This activity is supported by an independent educational grant from AMAG Pharmaceuticals, Inc.

 

For women, sexual health involves both body and mind. Conditions that compromise a woman’s sexual health interfere with intimacy and ultimately impact all areas of her well-being. Hypoactive sexual desire disorder (HSDD) is the most common of the female sexual dysfunctions. HSDD occurs in women of all ages but is continuously underdiagnosed and undermanaged.

The articles in this CME journal supplement comprehensively address the areas of concern that inhibit women’s healthcare clinicians in effectively addressing HSDD—namely patient communications, diagnostic strategies, and therapeutic modalities for treating HSDD. The information presented will allow these healthcare providers to implement strategies that will improve the sexual health of their patients presenting with HSDD, with the intent of improving these patients’ overall sense of well-being.

Click here to read the supplement.

To access the posttest and evaluation and claim credit, visit: www.omniaeducation.com/hsdd

Recommended Reading

Recognition, evaluation, and management of postpartum hypertension
MDedge ObGyn
Postpartum hypertension
MDedge ObGyn
2018 FDA-approved new drugs
MDedge ObGyn
FDA panel calls for changes to breast implant rupture screening
MDedge ObGyn
New postmenopausal osteoporosis guidelines emphasize patient priorities
MDedge ObGyn